Literature DB >> 15947082

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

Joseph R Berger, Igor J Koralnik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15947082     DOI： 10.1056/NEJMe058122

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  70 in total

Review 1.  Trafficking of immune cells in the central nervous system.

Authors:  Emma H Wilson; Wolfgang Weninger; Christopher A Hunter
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

Review 2.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 3.  Structural evaluation of new human polyomaviruses provides clues to pathobiology.

Authors:  Edward M Johnson
Journal:  Trends Microbiol       Date:  2010-02-20       Impact factor: 17.079

4.  Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells.

Authors:  Christian Wüthrich; Santosh Kesari; Woong-Ki Kim; Kenneth Williams; Rebecca Gelman; Derek Elmeric; Umberto De Girolami; Jeffrey T Joseph; Tessa Hedley-Whyte; Igor J Koralnik
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

5.  Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary.

Authors:  John Hallenbeck; Gregory Del Zoppo; Tom Jacobs; Antoine Hakim; Stephen Goldman; Ursula Utz; Ahmed Hasan
Journal:  Stroke       Date:  2006-11-02       Impact factor: 7.914

6.  Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.

Authors:  Marco A Lima; Angela Marzocchetti; Patrick Autissier; Troy Tompkins; Yiping Chen; Jennifer Gordon; David B Clifford; Rajesh T Gandhi; Nagagopal Venna; Joseph R Berger; Igor J Koralnik
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 7.  First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.

Authors:  Jacqueline Ann Nicholas; Michael Karl Racke; Jamie Imitola; Aaron Lee Boster
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

8.  Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient.

Authors:  F Bernal-Cano; J T Joseph; I J Koralnik
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

9.  Pharmacology of AMG 181, a human anti-α4 β7 antibody that specifically alters trafficking of gut-homing T cells.

Authors:  W J Pan; H Hsu; W A Rees; S P Lear; F Lee; I N Foltz; P Rathanaswami; K Manchulenko; B M Chan; M Zhang; X Z Xia; S K Patel; P J Prince; D R Doherty; C M Sheckler; K O Reynhardt; C D Krill; B J Harder; J A Wisler; J L Brandvig; J L Lynch; A A Anderson; L C Wienkers; D C Borie
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 10.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.